The global epidemiology of antibiotic-resistant Neisseria gonorrhoeae
JAC-Antimicrobial Resistance · 31.10.2026 · 8 (6)
DOI: 10.1093/jacamr/dlag245 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 03.11.2026. Verfasst von Matthew Ho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA. Die Arbeit nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Antimicrobial-resistant Neisseria gonorrhoeae is an evolving global public health threat that increasingly limits treatment options for one of the world’s most common sexually transmitted infections. This review synthesizes the global epidemiology of antimicrobial resistance in N. gonorrhoeae across phenotypic, genomic, clinical and population-level dimensions. Resistance to agents no longer recommended for empiric treatment is widespread, while azithromycin resistance and reduced susceptibility to extended-spectrum cephalosporins continue to emerge. Resistant lineages, including internationally disseminated ceftriaxone-resistant and extensively drug-resistant strains, highlight the capacity of N. gonorrhoeae to acquire and spread resistance across geographic and genetic backgrounds. However, the global burden remains difficult to quantify because surveillance is uneven, extragenital and asymptomatic infections are underrepresented and susceptibility testing methods and interpretive thresholds vary across settings. Resistance is shaped by antimicrobial exposure, sexual network dynamics, international travel, delayed diagnosis and treatment and structural barriers to sexual healthcare. Opportunities to mitigate resistance include more representative and standardized phenotypic and genomic surveillance; diversified treatment strategies including aetiologic point-of-care diagnostics, rapid resistance-guided therapy and newly available oral agents and strengthened prevention efforts through partner notification and treatment and vaccine development. Coordinated, locally informed implementation of those approaches may help preserve effective treatment and reduce the impact of antimicrobial resistance.
Autor:innen und Institutionen
- Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
- Division of Infectious Diseases, Department of Medicine, School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
ORCID-Profile: Matthew Ho, Paul C Adamson
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Ho, M., Adamson, P. C., Klausner, J. D., & Allan-Blitz, L. T. (2026). The global epidemiology of antibiotic-resistant Neisseria gonorrhoeae. JAC-Antimicrobial Resistance, 8(6). https://doi.org/10.1093/jacamr/dlag245
Vancouver
Ho M, Adamson PC, Klausner JD, Allan-Blitz LT. The global epidemiology of antibiotic-resistant Neisseria gonorrhoeae. JAC-Antimicrobial Resistance. 2026;8(6). doi:10.1093/jacamr/dlag245
BibTeX
@article{Ho2026,
author = {Ho, Matthew and Adamson, Paul C and Klausner, Jeffrey D and Allan-Blitz, Lao-Tzu},
title = {The global epidemiology of antibiotic-resistant Neisseria gonorrhoeae},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {6},
doi = {10.1093/jacamr/dlag245}
}
EUVIMED